The influence of baseline expression of human decay accelerating factor transgene on graft survival and acute humoral xenograft rejection

Transplantation

Volumn 80, Issue 9, 2005, Pages 1331-1339

  Sun, Hongtao ^a   Chen, Gang ^a   Liu, Weihua ^a   Kubelik, Dalibor ^a   Yang, Hongji ^a   White, David J ^a,b,c,d   Zhong, Robert ^a,b,c,d   Garcia, Bertha ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Acute humoral xenograft rejection; Human decay accelerating factor; Immunohistochemistry; Kidney; Xenotransplantation

Indexed keywords

DECAY ACCELERATING FACTOR;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BABOON; CORRELATION ANALYSIS; GRAFT SURVIVAL; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; NECROSIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; SWINE; TRANSGENE; TRANSGENIC ANIMAL; XENOGRAFT; XENOTRANSPLANTATION;

ACUTE DISEASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; CELL DEATH; ENDOTHELIUM; GENE EXPRESSION; GLOMERULAR MESANGIUM; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY; KIDNEY TRANSPLANTATION; PAPIO; SEVERITY OF ILLNESS INDEX; SWINE; TRANSGENES; TRANSPLANTATION, HETEROLOGOUS;

EID: 28544445587     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000177649.30721.31     Document Type: Article

References (42)

1. Langford GA, Yannoutsos N, Cozzi E, et al. Production of pigs transgenic for human decay accelerating factor. Transplant Proc 1994; 26(3): 1400.
2. Cozzi E, Langford GA, Richards A, et al. Expression of human decay accelerating factor in transgenic pigs. Transplant Proc 1994; 26(3): 1402.
3. Rosengard AM, Cary NR, Langford GA, et al. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 1995; 59(9): 1325.
4. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995; 1(5): 423.
5. Schuurman HJ, Pino-Chavez G, Phillips MJ, et al. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAP-transgenic donors. Transplantation 2002; 73(7): 1146.
6. Bhatti FN, Zaidi A, Schmoeckel M, et al. Survival of life-supporting hDAF transgenic kidneys in primates is enhanced by splenectomy. Transplant Proc 1998; 30(5): 2467.
7. Zaidi A, Schmoeckel M, Bhatti F, et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65(12): 1584.
8. Cozzi E, Bhatti F, Schmoeckel M, et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70(1): 15.
9. Zhong R, Chen G, Sun F, et al. Pig-to-baboon transplantation using hDAF-transgenic donors: 4 years experience at a Canadian center. Xenotransplantion 2003; 10(5): 481.
10. Higgins J, Lam T, Schuurman H, et al. Glomerular thrombotic microangiopathy in renal xenografts from hDAF-transgenic pigs into cynomolgus monkeys. Xenotransplantion 2001; 8(9): 44.
11. Manez R, Mosquera J, Lopez-Pelaez E, et al. Non-anti-αGal/non-anti- pig haemolytic antibodies may cause acute humoral xenograft rejection in hDAF pig-to-baboon kidney xenotransplantation. Xenotransplantion 2003; 10(5): 487 .
12. Cowan PJ, Aminian A, Barlow H, et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppresssed baboons. Transplantation 2000; 69(12): 2504.
13. Ghanekar A, Luo Y, Yang H, et al. The alpha-Gal analog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenografts. Transplant Proc 2001; 33(7-8):3853.
14. Richards AC, Davies HF, McLaughlin ML, et al. Serum anti-pig antibodies as potential indicators of acute humoral xenograft rejection in pig-to-cynomolgus monkey kidney transplantation. Transplantation 2002; 73(6): 881.
15. Zhong R, Luo Y, Yang H, et al. Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of ?gal. Transplantation 2003; 75(1): 10.
16. Lam TT, Hausen B, Boeke-Purkis K, et al. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914. Xenotransplantation 2004; 11(6): 517.
17. Lam TT, Boeke-Purkis K, Lau M, et al. Anti-pig antibody levels in non-human primates of various origin. Xenotransplantation 2004; 11(4): 332.
18. Garcia B, Sun HT, Yang HJ, et al. Xenotransplantation of human decay accelerating factor transgenic porcine kidney to non-human primates: 4 years experience at a Canadian center. Transplant Proc 2004; 36(6): 1714.
19. Lavitrano M, Bacci M, Formi M, et al. Efficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation. Proc Natl Acad Sci U S A 2002; 99(22): 14230.
20. Murakami H, Nagashima H, Takahagi Y, et al. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter. Mol Reprod Dev 2002; 61(3): 302.
21. Shapiro R, Tzakis AG, Scantlebury V, et al. , Immunodepletion in xenotransplantation. J Invest Surg 1990; 3(1): 39.
22. Brauer RB, Baldwin WM 3rd, Daha, MR, et al. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 1993; 151(12): 7240.
23. Haberal MA, Ppovtzer MM, McDonald KM, et al. Failure of angiotensin II inhibitor to modify hyperacute rejection. Surgery 1975; 78(2): 149.
24. Leventhal JR, Flores HC, Gruber SA, et al. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 1992; 54(1): 26.
25. Pruitt SK,WeinstockD, Suyemoto MM, et al. The effect of bursectomy on natural xenoreactive antibodies and vascularized rat cardiac xenograft rejection in the chicken. Transplantation 1993; 55(5): 1139.
26. Pruitt S, Bollinger RR, Collins BH, et al. Continuous complement (C) inhibition using soluble C receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts. Transplant Proc 1996; 28(2): 756.
27. Pruitt SK, Bollinger RR, Collins BH, et al. Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. Transplantation 1997; 63(6): 900.
28. Rajasinghe HA, Reddy VM, Hancock WW, et al. Key role of the alternate complement pathway in hyperacute rejection of rat hearts transplanted into fetal sheep. Transplantation 1996; 62(3): 407.
29. Cosio FG, Shibata T, Rovin BH, Birmingham DJ. Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells. Kidney Int 1994; 46(4): 986.
30. Higgins PJ, Ko JL, Lobell R, et al. A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities. J Immunol 1997; 158(6): 2872.
31. Hourcade DE, Mitchell LM, Medof ME. Decay acceleration of the complement alternative pathway C3 convertase. Immunopharmacology. 1999; 42(1-3): 167.
32. Perez de la Lastra JM, Harris CL, Hinchliffe SJ, et al. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats. J Immunol 2000; 165: 2563.
33. Buhler L, Yamada K, Alwayn I, et al. Miniature swine and hDAF pig kidney transplantation in baboons treated with a nonmyeloablative regimen and CD154 blockade. Transplant Proc 2001; 33(1-2): 716.
34. Buhler L, Yamada K, Kitamura H, et al. Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation 2001; 72(11): 1743.
35. Cozzi E, Vial C, Ostlie D, et al. Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts. Xenotransplantation 2003; 10(4): 300.
36. Ghanekar A, Lajoie G, Luo Y, et al. Treatment with rabbit antithymocyte serum permits a cyclophosphamide-free approach to prevention of hDAF transgenic porcine kidney xenograft rejection in baboons. Transplant Proc 2001; 33(7-8): 3849.
37. Knosalla C, Gollackner B, Buhler L, et al. Correlation of biochemical and hematological changes with graft failure following pig heart and kidney transplantation in baboons. Am J Transplant 2003; 3(12): 1510.
38. Ramirez P, Chavez R, Majado M, et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 2000; 70(7): 989.
39. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55(4): 857.
40. Chen G, Sun QY, Wang XM, et al. Improved suppression of circulating complement does not block acute vascular rejection of pig-to-rhesus monkey cardiac transplants. Xenotransplantation 2004; 11(2): 123.
41. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57(3): 363.
42. Shimizu A, Meehan SM, Kozlowski T, et al. Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to nonhuman primate renal grafts. Lab Invest 2000; 80(6): 815.